175 related articles for article (PubMed ID: 38394781)
21. Selecting targeted therapies for patients with renal cell carcinoma.
Plimack ER; Hudes GR
J Natl Compr Canc Netw; 2011 Sep; 9(9):997-1006; quiz 1007. PubMed ID: 21917624
[TBL] [Abstract][Full Text] [Related]
22. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Escudier B; Porta C; Schmidinger M; Rioux-Leclercq N; Bex A; Khoo V; Gruenvald V; Horwich A;
Ann Oncol; 2016 Sep; 27(suppl 5):v58-v68. PubMed ID: 27664262
[No Abstract] [Full Text] [Related]
23. SEOM clinical guideline for treatment of kidney cancer (2017).
Gallardo E; Méndez-Vidal MJ; Pérez-Gracia JL; Sepúlveda-Sánchez JM; Campayo M; Chirivella-González I; García-Del-Muro X; González-Del-Alba A; Grande E; Suárez C
Clin Transl Oncol; 2018 Jan; 20(1):47-56. PubMed ID: 29134564
[TBL] [Abstract][Full Text] [Related]
24. NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy.
Hudes GR; Carducci MA; Choueiri TK; Esper P; Jonasch E; Kumar R; Margolin KA; Michaelson MD; Motzer RJ; Pili R; Roethke S; Srinivas S
J Natl Compr Canc Netw; 2011 Feb; 9 Suppl 1(0 1):S1-29. PubMed ID: 21335444
[TBL] [Abstract][Full Text] [Related]
25. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Escudier B; Porta C; Schmidinger M; Algaba F; Patard JJ; Khoo V; Eisen T; Horwich A;
Ann Oncol; 2014 Sep; 25 Suppl 3():iii49-56. PubMed ID: 25210086
[No Abstract] [Full Text] [Related]
26. NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.
Schmults CD; Blitzblau R; Aasi SZ; Alam M; Amini A; Bibee K; Bolotin D; Bordeaux J; Chen PL; Contreras CM; DiMaio D; Donigan JM; Farma JM; Ghosh K; Harms K; Ho AL; Lukens JN; Manber S; Mark L; Medina T; Nehal KS; Nghiem P; Olino K; Park S; Patel T; Puzanov I; Rich J; Sekulic A; Shaha AR; Srivastava D; Thomas V; Tomblinson C; Venkat P; Xu YG; Yu S; Yusuf M; McCullough B; Espinosa S
J Natl Compr Canc Netw; 2024 Jan; 22(1D):e240002. PubMed ID: 38244274
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in renal cell carcinoma.
Shuch BM; Lam JS; Belldegrun AS; Figlin RA
Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of renal cell carcinoma.
Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
[TBL] [Abstract][Full Text] [Related]
29. NCCN practice guidelines for kidney cancer. National Comprehensive Cancer Network.
Oncology (Williston Park); 1998 Nov; 12(11A):396-412. PubMed ID: 10028523
[No Abstract] [Full Text] [Related]
30. [New trends in the diagnosis and treatment of renal cell carcinoma].
Zisman A
Harefuah; 2002 Aug; 141(8):713-7, 761. PubMed ID: 12222136
[TBL] [Abstract][Full Text] [Related]
31. Kidney cancer. Clinical practice guidelines in oncology.
Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar K; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
J Natl Compr Canc Netw; 2006 Nov; 4(10):1072-81. PubMed ID: 17112454
[No Abstract] [Full Text] [Related]
32. Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma.
Smaldone MC; Fung C; Uzzo RG; Haas NB
Hematol Oncol Clin North Am; 2011 Aug; 25(4):765-91. PubMed ID: 21763967
[TBL] [Abstract][Full Text] [Related]
33. Renal cell cancer: overview of the current therapeutic landscape.
Erman M; Benekli M; Basaran M; Bavbek S; Buyukberber S; Coskun U; Demir G; Karabulut B; Oksuzoglu B; Ozkan M; Sevinc A; Yalcin S
Expert Rev Anticancer Ther; 2016 Sep; 16(9):955-68. PubMed ID: 27548347
[TBL] [Abstract][Full Text] [Related]
34. Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines.
Frascà GM; Brigante F; Volpe A; Cosmai L; Gallieni M; Porta C
J Nephrol; 2019 Feb; 32(1):57-64. PubMed ID: 30328092
[TBL] [Abstract][Full Text] [Related]
35. [Renal cell carcinoma].
Fornara P; Hoda MR
Urologe A; 2011 Sep; 50 Suppl 1():219-22. PubMed ID: 21837488
[TBL] [Abstract][Full Text] [Related]
36. [Geriatric specificities of localized renal cell carcinoma].
Mongiat-Artus P; Paillaud E; Caillet P; Albrand G; Neuzillet Y
Prog Urol; 2019 Nov; 29(14):865-873. PubMed ID: 31771769
[TBL] [Abstract][Full Text] [Related]
37. Renal cell carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Escudier B; Kataja V;
Ann Oncol; 2009 May; 20 Suppl 4():81-2. PubMed ID: 19454473
[No Abstract] [Full Text] [Related]
38. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.
Schmults CD; Blitzblau R; Aasi SZ; Alam M; Andersen JS; Baumann BC; Bordeaux J; Chen PL; Chin R; Contreras CM; DiMaio D; Donigan JM; Farma JM; Ghosh K; Grekin RC; Harms K; Ho AL; Holder A; Lukens JN; Medina T; Nehal KS; Nghiem P; Park S; Patel T; Puzanov I; Scott J; Sekulic A; Shaha AR; Srivastava D; Stebbins W; Thomas V; Xu YG; McCullough B; Dwyer MA; Nguyen MQ
J Natl Compr Canc Netw; 2021 Dec; 19(12):1382-1394. PubMed ID: 34902824
[TBL] [Abstract][Full Text] [Related]
39. Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma.
Wu Y; Kwon YS; Labib M; Foran DJ; Singer EA
Dis Markers; 2015; 2015():648495. PubMed ID: 26609190
[TBL] [Abstract][Full Text] [Related]
40. The expanding role of imaging in the management of renal cell carcinoma.
Murphy G; Jhaveri K
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1871-88. PubMed ID: 22117155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
